Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.
Murakami M, Ishikawa H, Sekino Y, Nishiyama H, Suzuki H, Sugahara S, Iizumi T, Mizumoto M, Okumura T, Keino N, Iizumi Y, Hashimoto K, Gosho M, Sakurai H.
Murakami M, et al. Among authors: hashimoto k.
J Radiat Res. 2024 May 23;65(3):402-407. doi: 10.1093/jrr/rrae026.
J Radiat Res. 2024.
PMID: 38739903
Free article.
Clinical Trial.